Defense Speak Interpreted: Is DARPA Still Around After CHIPS?
Beyond the Board: Orbital High Ground—Why Space Superiority Is Slipping Away
The Government Circuit: Trump’s Trade War Disrupts the Electronics Ecosystem
U.S. DOD Awards $5.1M to Humanetics for Continued Development of Radiation Countermeasure
June 22, 2022 | Business WireEstimated reading time: 1 minute
Minneapolis-based Humanetics Corporation (Humanetics) has entered into a new $5.1 million cooperative research agreement with the U.S. Department of Defense (DOD) to continue advanced development of BIO 300, a medical countermeasure to protect military personnel and first responders from the harm caused by radiation exposure.
The new funding will be used to create, manufacture, and test a new formulation of BIO 300 that can be self-administered using an auto injector. Auto injectors are commonly used by the military to deliver fast-acting drugs such as atropine and naloxone. This new formulation of BIO 300 will complement the existing suite of oral formulations in the Humanetics portfolio that have been tested extensively and are in phase 2 trials. It is envisioned that the DOD would have access to both oral and auto injectable forms of BIO 300, which each have a unique use case.
“With the increasing potential for use of radiological or nuclear weaponry in the current global environment, especially with events in Ukraine, it’s a strategic imperative to protect our armed forces and first responders from radiation exposure and enable them to operate in areas of concern,” said Ronald Zenk, President and CEO at Humanetics.
BIO 300’s radioprotective attributes were originally discovered by researchers within the DOD at the Armed Forces Radiobiology Research Institute. The drug was licensed to Humanetics Corporation, which is leading its advanced development toward FDA approval. In parallel to the drug’s development for use as a medical countermeasure, Humanetics is evaluating the drug in clinical trials to determine its potential to reduce the toxic side effects of radiation in cancer patients and to reduce lung damage in COVID-19 long-haulers.
“We are enthused and encouraged by the DOD’s continued investment in the development of BIO 300 as a medical countermeasure,” said Zenk. “We see this drug not only providing protection for our warfighters, but also for our embassy personnel around the world and civilian populations who are at risk of radiation exposure from nuclear incidents and, furthermore, to improve the lives of cancer and COVID-19 patients.”
Share on:
Suggested Items
Beyond the Board: Orbital High Ground—Why Space Superiority Is Slipping Away
06/17/2025 | Jesse Vaughan -- Column: Beyond the Board“The next war might be won—or lost—22,000 miles above Earth.” That’s not science fiction. It’s the stark reality defense planners are beginning to confront as space transitions from a support domain to a full-spectrum warfighting environment. For decades, the United States held an uncontested advantage in space, relying on exquisite, few, and highly capable systems to enable precision warfare, real-time intelligence, and global communications. Today, that edge is under siege.
L3Harris Providing Additional VAMPIRE Counter-UAS Systems to Department of Defense
06/12/2025 | L3Harris TechnologiesL3Harris Technologies has received a new contract through the U.S. Department of Defense for additional VAMPIRE systems, which neutralize unmanned aerial threats.
BAE Systems Unveils Comprehensive Line of M-Code GPS Receivers at Joint Navigation Conference
06/04/2025 | PRNewswireBAE Systems unveiled a diverse line of M-Code Global Positioning System (GPS) receiver solutions at the Joint Navigation Conference in Cincinnati this week, rounding out an extensive line of products that ensure U.S. warfighters have the most dependable GPS systems available across sea, land, and air.
Another Lockheed Martin-Built GPS III Satellite Lifts Off into Orbit
06/02/2025 | Lockheed MartinThe eighth GPS III space vehicle—designed and built by Lockheed Martin—successfully launched from Cape Canaveral Space Force Station, Florida. It achieved signal acquisition shortly thereafter.
U.S. Holiday: Memorial Day
05/26/2025 | I-Connect007Memorial Day is a U.S. federal holiday dedicated to remembering and grieving for military personnel who died serving in the U.S. Armed Forces. Held on the last Monday of May, it also marks the unofficial start of summer.